August 5-9, 2019 | Boston MA
Applied BioMath Presence
In addition to the presentation listed below, Applied BioMath will have a booth at the Immuno-Oncology Summit.
Presentation time: Wednesday, August 7 at 10AM
Presentation title: Model Aided Drug Invention: In Silico Differentiation in I/O and Predicting Optimal Drug Properties in OA
Speaker: John Burke, PhD, Co-Founder, President and CEO, Applied BioMath, LLC
Presentation abstract: Model Aided Drug Invention is a mathematical modeling and engineering approach to translational medicine that quantitatively integrates knowledge about therapeutics with an understanding of its mechanism of action in the context of human disease mechanisms. Two case studies will explore integrating mathematical modeling to predict optimal drug properties targeting PD-1 and TIM3 in immuno-oncology for bispecific biologics and fixed dose combinations and determining best in class properties for targeted anabolic growth factor to arthritic joints.